Literature DB >> 2070345

Biological safety cabinetry.

R H Kruse1, W H Puckett, J H Richardson.   

Abstract

The biological safety cabinet is the one piece of laboratory and pharmacy equipment that provides protection for personnel, the product, and the environment. Through the history of laboratory-acquired infections from the earliest published case to the emergence of hepatitis B and AIDS, the need for health care worker protection is described. A brief description with design, construction, function, and production capabilities is provided for class I and class III safety cabinets. The development of the high-efficiency particulate air filter provided the impetus for clean room technology, from which evolved the class II laminar flow biological safety cabinet. The clean room concept was advanced when the horizontal airflow clean bench was manufactured; it became popular in pharmacies for preparing intravenous solutions because the product was protected. However, as with infectious microorganisms and laboratory workers, individual sensitization to antibiotics and the advent of hazardous antineoplastic agents changed the thinking of pharmacists and nurses, and they began to use the class II safety cabinet to prevent adverse personnel reactions to the drugs. How the class II safety cabinet became the mainstay in laboratories and pharmacies is described, and insight is provided into the formulation of National Sanitation Foundation standard number 49 and its revisions. The working operations of a class II cabinet are described, as are the variations of the four types with regard to design, function, air velocity profiles, and the use of toxins. The main certification procedures are explained, with examples of improper or incorrect certifications. The required levels of containment for microorganisms are given. Instructions for decontaminating the class II biological safety cabinet of infectious agents are provided; unfortunately, there is no method for decontaminating the cabinet of antineoplastic agents.

Entities:  

Mesh:

Year:  1991        PMID: 2070345      PMCID: PMC358192          DOI: 10.1128/CMR.4.2.207

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  100 in total

1.  [on anthrax immunity following the effect on the body of ionizing radiations].

Authors:  E I SILANT'EV; V A ANKUDINOV; S G KOLESOV
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1962-11

2.  Incidence of tuberculosis among workers in medical laboratories.

Authors:  D D REID
Journal:  Br Med J       Date:  1957-07-06

3.  Potential infectious hazards of laboratory techniques. I. Lyophilization.

Authors:  M REITMAN; M L MOSS; J B HARSTAD; R L ALG; N H GROSS
Journal:  J Bacteriol       Date:  1954-11       Impact factor: 3.490

4.  Incidence of tuberculosis, hepatitis, brucellosis, and shigellosis in British medical laboratory workers.

Authors:  J M Harrington; H S Shannon
Journal:  Br Med J       Date:  1976-03-27

5.  A twenty-five year review of laboratory-acquired human infections at the National Animal Disease Center.

Authors:  C D Miller; J R Songer; J F Sullivan
Journal:  Am Ind Hyg Assoc J       Date:  1987-03

6.  Mutagenicity in urine of nurses handling cytostatic drugs.

Authors:  K Falck; P Gröhn; M Sorsa; H Vainio; E Heinonen; L R Holsti
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

7.  Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential.

Authors:  S M Sieber; R H Adamson
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

8.  Special considerations in the use of vertical laminar-flow workbenches.

Authors:  K E Avis; J W Levchuk
Journal:  Am J Hosp Pharm       Date:  1984-01

9.  Viral hepatitis in Danish health care personnel, 1974-78.

Authors:  P Skinhøj; M Søeby
Journal:  J Clin Pathol       Date:  1981-04       Impact factor: 3.411

10.  Infections in British clinical laboratories, 1984-5.

Authors:  N R Grist; J A Emslie
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

View more
  12 in total

1.  Validation of cross-contamination control in biological safety cabinet for biotech/pharmaceutical manufacturing process.

Authors:  Shih-Cheng Hu; Angus Shiue; Jin-Xin Tu; Han-Yang Liu; Rong-Ben Chiu
Journal:  Environ Sci Pollut Res Int       Date:  2015-08-11       Impact factor: 4.223

2.  Characterization and control of airborne particles emitted during production of epoxy/carbon nanotube nanocomposites.

Authors:  Lorenzo G Cena; Thomas M Peters
Journal:  J Occup Environ Hyg       Date:  2011-02       Impact factor: 2.155

3.  Factors affecting detection of Brucella melitensis by BACTEC NR730, a nonradiometric system for hemocultures.

Authors:  C Gamazo; A I Vitas; I López-Goñi; R Díaz; I Moriyón
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

Review 4.  Laboratory-associated infections and biosafety.

Authors:  D L Sewell
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

5.  New technique: Development of a large-scale isolation chamber system for the safe and humane care of medium-sized laboratory animals harboring infectious diseases.

Authors:  Xin Pan; Jian-cheng Qi; Ming Long; Hao Liang; Xiao Chen; Han Li; Guang-bo Li; Hao Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2010-10       Impact factor: 3.066

6.  Validation of Contamination Control in Rapid Transfer Port Chambers for Pharmaceutical Manufacturing Processes.

Authors:  Shih-Cheng Hu; Angus Shiue; Han-Yang Liu; Rong-Ben Chiu
Journal:  Int J Environ Res Public Health       Date:  2016-11-12       Impact factor: 3.390

7.  Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues.

Authors:  Devendra T Mourya; Pragya D Yadav; Ajay Khare; Anwar H Khan
Journal:  Indian J Med Res       Date:  2017-10       Impact factor: 2.375

Review 8.  Facing highly infectious diseases: new trends and current concepts.

Authors:  P Brouqui
Journal:  Clin Microbiol Infect       Date:  2009-05-28       Impact factor: 8.067

9.  Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease.

Authors:  Philippe Brouqui; Vincenzo Puro; Francesco M Fusco; Barbara Bannister; Stephan Schilling; Per Follin; René Gottschalk; Robert Hemmer; Helena C Maltezou; Kristi Ott; Renaat Peleman; Christian Perronne; Gerard Sheehan; Heli Siikamäki; Peter Skinhoj; Giuseppe Ippolito
Journal:  Lancet Infect Dis       Date:  2009-05       Impact factor: 25.071

10.  Understanding the formation and behaviors of droplets toward consideration of changeover during cell manufacturing.

Authors:  Yuuki Ogawa; Manabu Mizutani; Ryuta Okamoto; Hideki Kitajima; Sachiko Ezoe; Masahiro Kino-Oka
Journal:  Regen Ther       Date:  2019-04-25       Impact factor: 3.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.